PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 6, 2026RSC Advances4 citationsOpen Access

Morpholine as a privileged scaffold for neurodegenerative disease therapeutics

SPSaranya Kattil ParmbilSKSunil KumarTRT. M. Rangarajan

Key Points

  • To highlight the significance of morpholine derivatives for treating neurodegenerative diseases and neuropsychiatric disorders.
  • Review existing literature on morpholine derivatives.
  • Analyze their applications in CNS therapeutics.
  • Morpholine derivatives show promise in central nervous system therapies.
  • Their use may fulfill unmet medical needs in neuropsychiatric treatments.

Abstract

The review emphasizes the importance of morpholine derivatives in advancing CNS therapeutics and their potential role in addressing unmet medical needs in neuropsychiatric disorder treatments.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Parmbil et al. (2026) studied this question.

synapsesocial.com/papers/69aa7087531e4c4a9ff5a68ehttps://doi.org/10.1039/d6ra00100a
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Methylphenidate in Healthy Adults2020 · 23 citations
  2. 2Organocatalyzed Protecting-Group-Free Total Synthesis of (S,S)- and (S,R)-Reboxetine, an Antidepressant Drug2022 · 5 citations
  3. 3Advanced Biomaterials in Neuroprotection: Innovations and Clinical Applications2025 · 33 citations
  4. 4Preclinical data on morpholine (3,5-di-tertbutyl-4-hydroxyphenyl) methanone induced anxiolysis2023 · 4 citations
  5. 5Adolescent Exposure to WIN 55212-2 Render the Nigrostriatal Dopaminergic Pathway Activated During Adulthood2020 · 7 citations